查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
先进伤口护理市场：2023年至2028年预测
市场调查报告书
商品编码
1410180

先进伤口护理市场：2023年至2028年预测

Advanced Wound Care Market - Forecasts from 2023 to 2028
出版日期: | 出版商: Knowledge Sourcing Intelligence | 英文 144 Pages | 商品交期: 最快1-2个工作天内

价格
简介目录

高级伤口护理市场预计在预测期内将以 4.52% 的复合年增长率增长，到 2028 年市场规模将从 2021 年的 31.33 亿美元达到 42.7 亿美元。

高级伤口护理是指治疗困难的慢性伤口。与标准伤口敷料相比，先进的伤口护理由新型材料和治疗方法组成，可促进更快、更有效的创伤治疗。人口老化、糖尿病和肥胖等慢性病的盛行率不断上升，以及对复杂伤口护理方法的了解不断增加，正在推动这一市场的扩张。透过水分管理、组织再生和感染控制促进创伤治疗、伤口护理设备和生物活性材料是先进伤口护理解决方案的例子。随着医疗保健专业人员和患者寻求更好的创伤治疗癒合，先进的伤口护理市场继续显着增长并在研发方面投入资金。

慢性伤口的增加推动先进伤口护理市场的成长

由于全球慢性伤口盛行率不断上升，先进伤口护理市场正在扩大。根据世界卫生组织的研究，糖尿病足溃疡、压疮和腿部静脉溃疡等慢性伤口影响数百万人，并导致巨大的医疗费用。糖尿病的流行、人口老化和生活方式的改变都会导致慢性伤口的增加。因此，医疗从业人员和患者需要更多的伤口护理解决方案，以实现更快、更有效的癒合，从而刺激了对新型伤口敷料、生物活性材料和伤口护理设备的需求。这一趋势正在推动先进伤口护理市场的成长，以满足对更好伤口护理的迫切需求。

糖尿病和肥胖症盛行率的增加正在推动先进伤口护理市场的成长。

由于全球糖尿病和肥胖症盛行率不断上升，先进的伤口护理市场正在扩大。根据国际糖尿病联盟的数据，2019 年约有 4.63 亿人患有糖尿病，预计到 2045 年将增加至 7 亿。糖尿病和肥胖是慢性溃疡的主要危险因素，包括糖尿病足溃疡和压疮。随着这些疾病的恶化，对先进伤口护理产品和治疗方法的需求不断增长，以解决糖尿病和肥胖患者伤口管理的独特挑战。医疗保健专业人员正在寻求新的伤口敷料和生物活性解决方案，以促进这些脆弱患者的癒合并预防问题，这正在推动市场扩张。

生物活性伤口护理产品的技术创新正在推动先进伤口护理市场的成长。

生物活性伤口护理产品的技术进步透过提供有效的伤口护理选择彻底改变了先进伤口护理市场。生物活性伤口护理方案与伤口环境相互作用并刺激组织再生。这些突破性产品包括先进敷料、生长激素和皮肤替代品。这些技术透过创造湿润、有利的环境、降低感染风险并促进组织恢復来改善创伤治疗。生物活性伤口护理解决方案的开发为医疗保健临床医生和患者提供了多种选择，以更有效地治疗复杂伤口、慢性溃疡和烧伤。随着该领域研究和开发的进步，市场可能会稳步扩大，改善患者的治疗效果并提供更高品质的伤口护理。

北美是先进伤口护理市场的领导者。

北美主导先进伤口护理市场。完善的卫生治疗系统、大量的慢性伤口患者以及人口老化支撑了该地区的优势。此外，大量的研发工作、技术改进和不断上涨的医疗成本也促进了北美先进伤口护理市场的成长。此外，重要市场参与企业的存在以及对新颖性伤口护理产品和治疗方法的关注也有助于该地区在该行业的领导地位。北美地区糖尿病和肥胖症等慢性病的盛行率不断上升，增加了对先进伤口护理的需求。

对更快、更有效的创伤治疗的日益关注将推动先进伤口护理市场的规模。

由于人们对更快、更有效的创伤治疗越来越感兴趣，先进的伤口护理市场正在不断扩大。健康从业者和患者正在寻求新颖的伤口护理解决方案，以加速创伤治疗并改善患者的治疗结果。加速创伤治疗正在引起人们的关注，其目的是缩短住院时间、降低医疗费用并提高患者的生活品质。为了满足这项需求，正在开发先进的伤口敷料、生长因子和生物活性产品，为组织再生提供有利的环境，同时降低感染风险。随着对快速有效的创伤治疗的需求越来越广泛地认识到，市场将继续增长以满足这种不断变化的需求。

主要进展

2023年7月，全球医疗科技公司Smith + Nephew宣布在印度推出REGENETEN生物感应植入物。 REGENETEN 植入物极大地影响了外科医生进行肩迴旋肌手术的方式，自推出以来，全球已实施了超过 100,000 例手术。基于胶原蛋白的 REGENETEN 生物感应植入物可促进新肌腱样组织的形成1-3,6，生理上补充现有肌腱并逆转疾病进展。 2023 年7 月，专门从事慢性病管理的富时100 强全球医疗产品和技术公司Convatec Group Plc 宣布推出用于Tandem Diabetes Care 的新型5 英寸输液器和Tandem Mobi，这是世界上最小的耐用自动胰岛素输送系统。我们宣布就一套产品进行合作，并于最近获得 FDA 510(k) 批准。 Convatec 是输液技术以及胰岛素帮浦插入设备设计和製造的全球领导者。

公司产品

  • 伤口敷料：泡棉敷料、亲水胶体敷料和硅胶敷料是施乐辉提供的先进伤口敷料。这些敷料旨在透过创造湿润的创伤治疗环境来促进创伤治疗。
  • 手术切口管理： Smith & Nephew 销售切口管理产品，包括黏合敷料和固定装置，以帮助伤口护理。
  • 亲水胶体敷料Molnlycke 提供有助于自溶解清创和创伤治疗的亲水胶体胶体敷料。
  • 硅胶敷料Molnlycke 提供硅胶伤口敷料。它对皮肤温和，能很好地黏附在伤口表面的凹凸处。
  • 亲水性纤维敷料敷料： ConvaTec 提供亲水性纤维敷料敷料，可吸收和密封多余的伤口渗出物，保持湿润的创伤治疗环境并改善创伤治疗。

目录

第一章简介

  • 市场概况
  • 市场定义
  • 调查范围
  • 市场区隔
  • 货币
  • 先决条件
  • 基准年和预测年时间表

第二章调查方法

  • 调查资料
  • 资讯来源
  • 研究设计

第三章执行摘要

  • 研究亮点

第四章市场动态

  • 市场驱动因素
  • 市场抑制因素
  • 波特五力分析
    • 供应商的议价能力
    • 买方议价能力
    • 新进入者的威胁
    • 替代品的威胁
    • 业内竞争对手之间的对抗关係
  • 产业价值链分析

第五章先进伤口护理市场：依产品类型

  • 介绍
  • 敷料
    • 泡棉敷料
    • 亲水胶体敷料
    • 海藻酸敷料
    • 膜敷料
    • 水凝胶敷料
    • 胶原蛋白敷料
    • 其他的
  • 伤口护理设备
    • 负压伤口护理(NPWT) 设备
    • 氧气及高压氧气设备
    • 电刺激设备
    • 超音波治疗仪
    • 其他的

第六章先进伤口护理市场：依伤口类型

  • 介绍
  • 糖尿病溃疡
  • 褥疮
  • 静脉溃疡
  • 外科性创伤
  • 烧伤
  • 其他的

第七章先进伤口护理市场：依最终用户分类

  • 介绍
  • 医院和诊所
  • 家庭治疗环境
  • 长期治疗中心
  • 门诊手术中心
  • 其他的

第八章先进伤口护理市场：按地区

  • 介绍
  • 北美洲
    • 美国
    • 加拿大
    • 墨西哥
  • 南美洲
    • 巴西
    • 阿根廷
    • 其他的
  • 欧洲
    • 英国
    • 德国
    • 法国
    • 义大利
    • 西班牙
    • 其他的
  • 中东/非洲
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 其他的
  • 亚太地区
    • 日本
    • 中国
    • 印度
    • 韩国
    • 印尼
    • 台湾
    • 其他的

第九章竞争环境及分析

  • 主要企业及策略分析
  • 新兴企业和市场盈利
  • 合併、收购、协议和合作
  • 供应商竞争力矩阵

第十章 公司简介

  • SMITH & NEPHEW PLC
  • ACELITY LP INC.（NOW PART OF 3M COMPANY）
  • MOLNLYCKE HEALTH CARE AB（NOW PART OF INVESTOR AB）
  • CONVATEC GROUP PLC
  • COLOPLAST A/S
  • INTEGRA LIFESCIENCES CORPORATION
  • B. BRAUN MELSUNGEN AG
  • 3M COMPANY
  • PAUL HARTMANN AG
  • MEDTRONIC PLC
简介目录
Product Code: KSI061615851

The advanced wound care market is projected to grow at a CAGR of 4.52% over the forecast period, increasing from US$3.133 billion in 2021 to a total market size of US$4.27 billion by 2028.

The advanced wound care refers to the treatment of difficult and chronic wounds. When compared to standard wound dressings, advanced wound care comprises novel materials and therapies that promote quicker and more efficient wound healing. The expansion of this market is being driven by factors such as an ageing population, an increase in the incidence of chronic conditions such as diabetes and obesity, and increased knowledge of sophisticated wound care therapies. Dressings, wound treatment devices, and bioactive materials that promote wound healing through moisture management, tissue regeneration, and infection control are examples of advanced wound care solutions. As healthcare practitioners and patients seek better wound healing results, the advanced wound care market continues to experience substantial developments and R&D expenditures.

Increasing Incidence of Chronic Wounds drives the Advanced Wound Care Market growth.

The advanced wound care market is expanding due to the rising prevalence of chronic wounds worldwide. According to World Health Organisation research, chronic wounds such as diabetic foot ulcers, pressure ulcers, and venous leg ulcers afflict millions of individuals, resulting in enormous healthcare costs. Diabetes prevalence, ageing populations, and lifestyle variables all lead to an increase in chronic wound cases. As a result, healthcare practitioners and patients are increasingly looking for enhanced wound care solutions that deliver quicker and more effective healing, fuelling demand for novel wound dressings, bioactive materials, and wound treatment devices. This trend is driving the growth of the advanced wound care market in order to meet the urgent demand for better wound treatment.

Growing Prevalence of Diabetes and Obesity Enhances the Advanced Wound Care Market Growth.

Because of the rising prevalence of diabetes and obesity worldwide, the advanced wound care market is expanding. According to the International Diabetes Federation, around 463 million individuals in 2019 had diabetes, with this figure expected to rise to 700 million by 2045. Diabetes and obesity are major risk factors for chronic sores including diabetic foot ulcers and pressure ulcers. As these illnesses worsen, there is a greater need for sophisticated wound care products and therapies that address the particular issues of wound management in diabetic and obese patients. Healthcare professionals are looking for novel wound dressings and bioactive solutions to enhance healing results and prevent problems in this vulnerable group, which is driving market expansion.

Technological Innovations in Bioactive Wound Care Products drive the Advanced Wound Care Market Growth.

Technological advancements in bioactive wound care products have revolutionised the advanced wound care market by giving efficient wound healing options. Bioactive wound care solutions interact with the wound environment to stimulate tissue regeneration. These revolutionary items include advanced dressings, growth hormones, and skin replacements. These technologies improve wound healing by creating a moist and favourable environment, lowering the risk of infection, and expediting tissue restoration. The development of bioactive wound care solutions provides healthcare clinicians and patients with a variety of choices for more effectively treating complicated wounds, chronic ulcers, and burns. As research and development in this discipline progresses, the market is likely to increase steadily, providing better patient outcomes and higher quality wound care.

North America is the Market Leader in the Advanced Wound Care Market.

North America dominates the advanced wound care market. A well-established healthcare system, a huge patient pool with chronic wounds, and an ageing population all contribute to the region's dominance. Furthermore, substantial R&D efforts, technical improvements, and increased healthcare expenditure all contribute to the advanced wound care market's growth in North America. Furthermore, the presence of important market participants, as well as a strong emphasis on novel wound care products and therapies, contribute to the region's leadership in this industry. The rising incidence of chronic illnesses including diabetes and obesity fuels demand for sophisticated wound care treatments in North America.

Growing Focus on Faster and Effective Wound Healing Bolsters the Advanced Wound Care Market Size.

The advanced wound care market is expanding due to a growing emphasis on quicker and more efficient wound healing. Healthcare practitioners and patients are looking for novel wound care solutions that help speed up healing and improve patient outcomes. The goal to shorten hospital stays, lower healthcare costs, and enhance patients' quality of life is driving the focus on speedier wound healing. To meet this need, advanced wound dressings, growth factors, and bioactive products are being developed, providing a favourable environment for tissue regeneration while reducing the risk of infection. As the need for speedy and effective wound healing becomes more widely recognised, the market is positioned for continued growth to satisfy these changing demands.

Key Developments:

  • In July 2023, The worldwide medical technology company Smith+Nephew has announced the introduction of their REGENETEN Bioinductive Implant in India. The REGENETEN implant has had a dramatic influence on the way surgeons approach rotator cuff surgeries, with over 100,000 procedures conducted globally since its inception. The collagen-based REGENETEN Bioinductive Implant facilitates the creation of new tendon-like tissue1-3,6 to physiologically supplement the existing tendon and reverse the course of disease progression.
  • In July 2023, Convatec Group Plc, an FTSE 100 global medical products and technologies company focused on chronic condition management announced a collaboration with Tandem Diabetes Care on a new five-inch infusion set for Tandem Mobi, the world's smallest durable automated insulin delivery system, which has now received FDA 510(k) clearance. Convatec is the global leader in the design and manufacture of infusion technology and insulin pump insertion devices.

Company Products:

  • Wound Dressings: Foam dressings, hydrocolloid dressings, and silicone dressings are among the advanced wound dressings available from Smith & Nephew. These dressings are intended to enhance successful wound healing by creating a moist wound-healing environment.
  • Surgical Incision Management: The firm sells surgical incision management items such as sticky dressings and securement devices to help with post-operative wound care.
  • Hydrocolloid Dressings: Molnlycke offers hydrocolloid dressings that aid in autolytic debridement and wound healing.
  • Silicone Dressings: Molnlycke provides silicone-based wound dressings that are soft on the skin and cling well to uneven wound surfaces.
  • Hydrofiber Dressings: ConvaTec provides hydrofiber dressings that absorb and seal away excess wound exudate, maintaining a moist wound-healing environment and improving wound healing.

Segmentation:

By Product Type

  • Dressings
  • Foam Dressings
  • Hydrocolloid Dressings
  • Alginate Dressings
  • Film Dressings
  • Hydrogel Dressings
  • Collagen Dressings
  • Others
  • Wound Therapy Devices
  • Negative Pressure Wound Therapy (Npwt) Devices
  • Oxygen And Hyperbaric Oxygen Equipment
  • Electrical Stimulation Devices
  • Ultrasound Therapy Devices
  • Others

By Wound Type

  • Diabetic Ulcers
  • Pressure Ulcers
  • Venous Ulcers
  • Surgical Wounds
  • Burns
  • Others

By End-User

  • Hospitals And Clinics
  • Home Care Settings
  • Long-Term Care Centers
  • Ambulatory Surgical Centers
  • Others

By Geography

  • North America
  • United States
  • Canada
  • Mexico
  • South America
  • Brazil
  • Argentina
  • Others
  • Europe
  • United Kingdom
  • Germany
  • France
  • Italy
  • Spain
  • Others
  • Middle East and Africa
  • Saudi Arabia
  • UAE
  • Others
  • Asia Pacific
  • Japan
  • China
  • India
  • South Korea
  • Indonesia
  • Taiwan
  • Others

TABLE OF CONTENTS

1. INTRODUCTION

  • 1.1. Market Overview
  • 1.2. Market Definition
  • 1.3. Scope of the Study
  • 1.4. Market Segmentation
  • 1.5. Currency
  • 1.6. Assumptions
  • 1.7. Base, and Forecast Years Timeline

2. RESEARCH METHODOLOGY

  • 2.1. Research Data
  • 2.2. Sources
  • 2.3. Research Design

3. EXECUTIVE SUMMARY

  • 3.1. Research Highlights

4.. MARKET DYNAMICS

  • 4.1. Market Drivers
  • 4.2. Market Restraints
  • 4.3. Porters Five Forces Analysis
    • 4.3.1. Bargaining Power of Suppliers
    • 4.3.2. Bargaining Power of Buyers
    • 4.3.3. Threat of New Entrants
    • 4.3.4. Threat of Substitutes
    • 4.3.5. Competitive Rivalry in the Industry
  • 4.4. Industry Value Chain Analysis

5. ADVANCED WOUND CARE MARKET, BY PRODUCT TYPE

  • 5.1. Introduction
  • 5.2. DRESSINGS
    • 5.2.1. FOAM DRESSINGS
    • 5.2.2. HYDROCOLLOID DRESSINGS
    • 5.2.3. ALGINATE DRESSINGS
    • 5.2.4. FILM DRESSINGS
    • 5.2.5. HYDROGEL DRESSINGS
    • 5.2.6. COLLAGEN DRESSINGS
    • 5.2.7. OTHERS
  • 5.3. WOUND THERAPY DEVICES
    • 5.3.1. NEGATIVE PRESSURE WOUND THERAPY (NPWT) DEVICES
    • 5.3.2. OXYGEN AND HYPERBARIC OXYGEN EQUIPMENT
    • 5.3.3. ELECTRICAL STIMULATION DEVICES
    • 5.3.4. ULTRASOUND THERAPY DEVICES
    • 5.3.5. OTHERS

6. ADVANCED WOUND CARE MARKET, BY WOUND TYPE

  • 6.1. Introduction
  • 6.2. DIABETIC ULCERS
  • 6.3. PRESSURE ULCERS
  • 6.4. VENOUS ULCERS
  • 6.5. SURGICAL WOUNDS
  • 6.6. BURNS
  • 6.7. OTHERS

7. ADVANCED WOUND CARE MARKET, BY END-USER

  • 7.1. Introduction
  • 7.2. HOSPITALS AND CLINICS
  • 7.3. HOME CARE SETTINGS
  • 7.4. LONG-TERM CARE CENTERS
  • 7.5. AMBULATORY SURGICAL CENTERS
  • 7.6. OTHERS

8. ADVANCED WOUND CARE MARKET, BY GEOGRAPHY

  • 8.1. Introduction
  • 8.2. North America
    • 8.2.1. United States
    • 8.2.2. Canada
    • 8.2.3. Mexico
  • 8.3. South America
    • 8.3.1. Brazil
    • 8.3.2. Argentina
    • 8.3.3. Others
  • 8.4. Europe
    • 8.4.1. United Kingdom
    • 8.4.2. Germany
    • 8.4.3. France
    • 8.4.4. Italy
    • 8.4.5. Spain
    • 8.4.6. Others
  • 8.5. Middle East and Africa
    • 8.5.1. Saudi Arabia
    • 8.5.2. UAE
    • 8.5.3. Others
  • 8.6. Asia Pacific
    • 8.6.1. Japan
    • 8.6.2. China
    • 8.6.3. India
    • 8.6.4. South Korea
    • 8.6.5. Indonesia
    • 8.6.6. Taiwan
    • 8.6.7. Others

9. COMPETITIVE ENVIRONMENT AND ANALYSIS

  • 9.1. Major Players and Strategy Analysis
  • 9.2. Emerging Players and Market Lucrativeness
  • 9.3. Mergers, Acquisitions, Agreements, and Collaborations
  • 9.4. Vendor Competitiveness Matrix

10. COMPANY PROFILES

  • 10.1. SMITH & NEPHEW PLC
  • 10.2. ACELITY L.P. INC. (NOW PART OF 3M COMPANY)
  • 10.3. MOLNLYCKE HEALTH CARE AB (NOW PART OF INVESTOR AB)
  • 10.4. CONVATEC GROUP PLC
  • 10.5. COLOPLAST A/S
  • 10.6. INTEGRA LIFESCIENCES CORPORATION
  • 10.7. B. BRAUN MELSUNGEN AG
  • 10.8. 3M COMPANY
  • 10.9. PAUL HARTMANN AG
  • 10.10. MEDTRONIC PLC